Source: BioPortfolio

Alcyonels: Alcyone Lifesciences gets breakthrough device designation from FDA for ThecaFlex DRx system

To qualify for the FDA&8217;s Breakthrough Device Program the medical device must provide more effective diagnosis or treatment of a lifethreatening or irreversible debilitating condition and either represent The post Alcyone Lifesciences gets breakthr...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
PJ Anand's photo - President & CEO of Alcyone Lifesciences, Inc.

President & CEO

PJ Anand

CEO Approval Rating

83/100

Read more